Impact of an audit program and other factors on door-to-balloon times in acute ST-elevation myocardial infarction patients destined for primary coronary intervention

Academic Emergency Medicine

Volumn 16, Issue 4, 2009, Pages 333-342

  Lai, Chao Lun ^a   Fan, Chieh Min ^a   Liao, Pen Chih ^a   Tsai, Kuang Chau ^a   Yang, Chi Yu ^a   Chu, Shu Hsun ^a   Chien, Kuo Liong ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Angioplasty; Catheterization; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG USE; EMERGENCY MEDICINE; FEEDBACK SYSTEM; FEMALE; GEOMETRY; HEART INFARCTION; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART CATHETERIZATION; HUMANS; LENGTH OF STAY; LINEAR MODELS; MALE; MEDICAL AUDIT; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RISK FACTORS; TAIWAN; THROMBASTHENIA; TIME FACTORS;

EID: 65449173582     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2009.00372.x     Document Type: Article

References (33)

1. Moscucci M, Eagle KA. Reducing the door-to- balloon time for myocardial infarction with ST- segment elevation. N Engl J Med. 2006; 355:2364-5.
2. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000; 283:2941-7.
3. Shavelle DM, Rasouli ML, Frederick P, Gibson CM, French WJ. Outcome in patients transferred for percutaneous coronary intervention (A National Registry of Myocardial Infarction 2/3/4 Analysis). Am J Cardiol. 2005; 96:1227-32.
4. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004; 44:671-719.
5. Van de Werf F, Ardissino D, et al. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2003; 24:28-66.
6. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Car- etiology/American Heart Association Task Force on Performance Measures. Circulation. 2006; 113:732-61.
7. Tran CTT, Lee DS, Flintoft VF, et al. CCORT/CCS quality indicators for acute myocardial infarction care. Can J Cardiol. 2003; 19:38-45.
8. McNamara RL, Herrin J, Bradley EH, et al. Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol. 2006; 47:45-51.
9. Bradley EH, Curry LA, Webster TR, et al. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation. 2006; 113:1079-85.
10. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocar- dial infarction. N Engl J Med. 2006; 355:2308-20.
11. Antman E, Bassand JP, Klein W, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol. 2000; 36:959-69.
12. Bland JM, Altman DG. Statistics notes: transformations, means, and confidence intervals. Br Med J. 1996; 312:1079.
13. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967; 20:457-64.
14. Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996; 49:907-16.
15. Wu EB, Arora N, Eisenhauer AC, Resnic FS. An analysis of door-to-balloon time in a single center to determine causes of delay and possibilities for improvement. Catheter Cardiovasc Interv. 2008; 71:152-7.
16. Angeja BG, Gibson CM, Chin R, et al. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol. 2002; 89:1156-61.
17. Heer T, Schiele R, Schneider S, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol. 2002; 89:511-7.
18. Cohen M, Gensini GF, Maritz F, et al. The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2005; 19:155-61.
19. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. Can Med Assoc J. 2007; 176:S1-44.
20. Song XT, Chen YD, Pan WQ, Lu SZ, CRACE investigators. Gender based differences in patients with acute coronary syndrome: findings from Chinese Registry of Acute Coronary Events (CRACE). Chin Med J. 2007; 120:1063-7.
21. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non- ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardio- logy/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005; 45:832-7.
22. Huey BL, Beller GA, Kaiser DL, Gibson RS. A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol. 1988; 12:1156-66.
23. Melendez LJ, Jones DT, Salcedo JR. Usefulness of three additional electrocardiographic chest leads (V7, V8, and V9) in the diagnosis of acute myocar- dial infarction. Can Med Assoc J. 1978; 119:745-8.
24. Brady WJ. Acute posterior wall myocardial infarction: electrocardiographic manifestations. Am J Emerg Med. 1998; 16:409-13.
25. Antman EM, Giugliano RP, Gibson CM, et al. Ab- ciximab facilitates the rate and extent of thromboly- sis: results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial. Circulation. 1999; 99:2720-32.
26. Van den Merkhof LF, Zijlstra F, Olsson H, et al. Ab-ciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study. J Am Coll Cardiol. 1999; 33:1528-32.
27. Zhao XQ, Theroux P, Snapinn SM, Sax FL. Intracor- onary thrombus and platelet glycoprotein Ilb/nia receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS Trial. Circulation 1999; 100:1609-15.
28. Bullard MJ, Liaw SJ, Chen JC. Emergency medicine development in Taiwan. Ann Emerg Med. 1996; 28:542-8.
29. Shih FY, Ma MH, Chen SC, et al. ED overcrowding in Taiwan: facts and strategies. Am J Emerg Med. 1999; 17:198-202.
30. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the ''obesity paradox'' in the Get With The Guidelines database. Am J Cardiol. 2007; 100:1331-5.
31. Diercks DB, Roe MT, Mulgund J, et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J. 2006; 152:140-8.
32. Khot UN, Johnson ML, Ramsey C, et al. Emergency department physician activation of the catheteriza- tion laboratory and immediate transfer to an immediately available catheterization laboratory reduce door-to-balloon time in ST-elevation myocardial infarction. Circulation 2007; 116:67-76.
33. Kraft PL, Newman S, Hanson D, Anderson W, Bastani A. Emergency physician discretion to activate the cardiac catheterization team decreases door-to-balloon time for acute ST-elevation myocar- dial infarction. Ann Emerg Med. 2007; 50:520-6.